logo de ProBioQual
Association for the Promotion of Quality Control in Medical Biology
COFRAC logo
Sub-family: General & specialised biochemistry Image Preeclampsia
2027 EQA PROGRAMS
EQA 2027 - Biological pre-eclampsia markers (PREE)
Expert Biologists - Program Coordinators:
Bernard POGGI, Magali PETTAZZONI, Louis LACAILLE and Laetitia SELMAN
EQA performed since 2020
Number of analytical sites registered in 2026: 47
Program organised by ProBioQual and placed under the aegis of the FAEEQ

1 – Program overview

This external quality assessment program assesses the accuracy of the assay of 3 serum markers used in the screening and monitoring of pre-eclampsia: sFlt-1 (Soluble fms-like tyrosine kinase-1), PAPP-A (Pregnancy-associated plasma protein A) and PlGF (Placental growth factor), as well as the estimation of the risk of pre-eclampsia in the 3rd trimester (sFlt-1/PlGF ratio) and in the 1st trimester (using demographic data provided for each sample).

2 – Assessment frequency

Number of surveys per year: 4
Number of control samples per survey: 1 or 2
Number of samples per year: 6

3 – List of analytes assessed 

  • sFlt-1
  • PlGF (pg/mL and MoM)
  • sFlt-1/PlGF ratio (3rd trimester pregnancy pre-eclampsia risk assessment)
  • PAPP-A
  • 1st trimester pregnancy pre-eclampsia risk assessment

4 – Description of the control samples

Lyophilised human control serum (samples to be resuspended in 1 mL of distilled water).

5 – Demographic data

Demographic data are provided to allow the calculation of 1st trimester pregnancy pre-eclampsia risk.

Contact us
ProBioQual
7, Rue Antoine Lumière - 69008 LYON - FRANCE
Tel: +33 (0)4 72 65 34 90
E-mail: secretariat@probioqual.com
| Legal notices and privacy policy | General terms of sale | Last updated: 13 October 2026 Copyright © 2011-2026 ProBioQual All rights reserved